Soluble MHC Class I chain-related molecule serum levels are predictive markers of implantation failure and successful term pregnancies following IVF

Human Reproduction

Volumn 22, Issue 8, 2007, Pages 2261-2266

  Porcu Buisson, Géraldine ^a,b   Lambert, Marion ^c   Lyonnet, Luc ^b   Loundou, Anderson ^d   Gamerre, Marc ^b   Camoin Jau, Laurence ^d,e   Dignat George, Franņoise ^b,e   Caillat Zucman, Sophie ^c   Paul, Pascale ^b,e  

^a Medical Institute of Reproduction   (France)

^b HÔPITAL DE LA CONCEPTION   (France)

^c HÔPITAL SAINT VINCENT DE PAUL   (France)

^d AIX MARSEILLE UNIVERSITY   (France)

^e INSERM   (France)

Author keywords

Assisted pregnancy; Implantation failure; IVF; Major histocompatibility complex Class I chain related; Natural killer

Indexed keywords

GONADORELIN AGONIST; GONADORELIN DERIVATIVE; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1 CHAIN RELATED MOLECULE; RECOMBINANT FOLLITROPIN; REGULATOR PROTEIN; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CELLULAR IMMUNITY; COHORT ANALYSIS; CONFIDENCE INTERVAL; CONTROLLED STUDY; DISEASE MARKER; FEMALE; FERTILIZATION IN VITRO; FOLLICULAR PHASE; HUMAN; INFERTILITY; MAJOR CLINICAL STUDY; NIDATION; NON INVASIVE MEASUREMENT; OVULATION INDUCTION; PREDICTION; PREGNANCY; PREGNANCY OUTCOME; PROTEIN BLOOD LEVEL; QUANTITATIVE ANALYSIS; SPONTANEOUS ABORTION; STATISTICAL SIGNIFICANCE;

EID: 34547806148     PISSN: 02681161     EISSN: 14602350     Source Type: Journal    
DOI: 10.1093/humrep/dem157     Document Type: Article

References (38)

1. Andre P, Castriconi R, Espeli M, Anfossi N, Juarez T, Hue S, Conway H, Romagne F, Dondero, A, Nanni M et al. Comparative analysis of human NK cell activation induced by NKG2D and natural cytotoxicity receptors. Eur J Immunol 2004;34:961-971.
2. Ashkar AA, Black GP, Wei Q, He H, Liang L, Head JR, Croy BA. Assessment of requirements for IL-15 and IFN regulatory factors in uterine NK cell differentiation and function during pregnancy. J Immunol 2003: 171:2937-2944.
3. Bryceson YT, March ME, Ljunggren HG, Long EO. Synergy among receptors on resting NK cells for the activation of natural cytotoxicity and cytokine secretion. Blood 2006;107:159-166.
4. Cárbone E, Neri P, Mesuraca M, Fulciniti MT, Otsuki T, Pende D, Groh V. Spies T, Pollio G, Cosman D et al. HLA class I, NKG2D, and natural cytotoxicity receptors regulate multiple myeloma cell recognition by natural killer cells. Blood 2005;105:251-258.
5. Coudert JD, Zimmer J, Tomasello E, Cebecauer M, Colonna M, Vivier E, Held W. Altered NKG2D function in NK cells induced by chronic exposure to NKG2D ligand-expressing tumor cells. Blood 2005;106 1711-1717.
6. Coulam CB, Roussev RG. Correlation of NK cell activation and inhibition markers with NK cytoxicity among women experiencing immunologic implantation failure after in vitro fertilization and embryo transfer. J Assist Reprod Genet 2003;20:58-62.
7. Fuzzi B, Rizzo R, Criscuoli L, Noci I, Melchiorri L, Scarselli B, Bencini E, Menicucci A, Baricordi OR. HLA-G expression in early embryos is a fundamental prerequisite for the obtainment of pregnancy. Eur J Immunol 2002;32:311-315.
8. Groh V, Bruhl A, El-Gabalawy H, Nelson JL, Spies T. Stimulation of T cell autoreactivity by anomalous expression of NKG2D and its MIC ligands in rheumatoid arthritis. Proc Natl Acad Sci USA 2003;100 9452-9457.
9. Groh V, Li YQ, Cioca D, Hunder NN, Wang W, Riddell SR, Yee C, Spies T. Efficient cross-priming of tumor antigen-specific T cells by dendritic cells sensitized with diverse anti-MICA opsonized tumor cells. Proc Natl Acad Sci USA 2005;102:6461-6466.
10. Groh V, Steinle A, Bauer S, Spies T. Recognition of stress-induced MHC molecules by intestinal epithelial gammadelta T cells. Science 1998; 279:1737-1740.
11. Groh V, Wu J, Yee C, Spies T. Tumour-derived soluble MIC ligands impair expression of NKG2D and T-cell activation. Nature 2002;419: 734-738.
12. Hanna J, Goldman-Wohl D, Hamani Y, Avraham I, Greenfield C, Natanson-Yaron S. Prus D, Cohen-Daniel L, Arnon TI, Manaster I et al. Decidual NK cells regulate key developmental processes at the human fetal-maternal interface. Nat Med 2006;12:1065-1074.
13. Hayakawa Y, Smyth MJ. NKG2D and cytotoxic effector function in tumor immune surveillance. Semin Immunol 2006;18:176-185.
14. Hiby SE, Walker JJ, O'Shaughnessy KM, Redman CW, Carrington M, Trowsdale J, Moffett A. Combinations of maternal KIR and fetal HLA-C gems influence the risk of preeclampsia and reproductive success. J Exp Med 2004;200:957-965.
15. Hue S, Mention JJ, Monteiro RC, Zhang S, Cellier C, Schmitz J, Verkarre V, Fodil N, Bahram S, Cerf-Bensussan N et al. A direct role for NKG2D/MICA interaction in villous atrophy during celiac disease. Immunity 2004;21:367-377.
16. Jamieson AM, Diefenbach A, McMahon CW, Xiong N, Carlyle JR, Raulet DH. The role of the NKG2D immunoreceptor in immune cell activation and natural killing. Immunity 2002: 17:19-29.
17. Lanier LL. NK cell recognition. Annu Rev Immunol 2005;23 225-274.
18. Ledee-Bataille N, Dubanchet S, Coulomb-L'hermine A, Durand-Gasselin I, Frydman R, Chaouat G. A new role for natural killer cells, interleukin (IL)-12, and IL-18 in repeated implantation failure after in vitro fertilization. Fertil Steril 2004;81:59-65.
19. Meloni GF, Dessole S, Vargiu N, Tomasi PA, Musumeci S. The prevalence of coeliac disease in infertility. Hum Reprod 1999;14:2759-2761.
20. Meresse B, Chen Z, Ciszewski C, Tretiakova M, Bhagat G, Krausz TN, Raulet DH, Lanier LL, Groh V, Spies T et al. Coordinated induction by IL15 of a TCR-independent NKG2D signaling pathway converts CTL into lymphokine-activated killer cells in celiac disease. Immunity 2004;21: 357-366.
21. Mincheva-Nilsson L, Nagaeva O, Chen T, Stendahl U, Antsiferova J, Mogren I, Hernestal J, Baranov V. Placenta-derived soluble MHC class I chain-related molecules down-regulate NKG2D receptor on peripheral blood mononuclear cells during human pregnancy: A possible novel immune escape mechanism for fetal survival. J Immunol 2006;176:3585-3592.
22. Moffett-King A. Natural killer cells and pregnancy. Nat Rev Immunol 2002;2:656-663.
23. Parham P. NK cells and trophoblasts: Partners in pregnancy. J Exp Med 2004;200:951-955.
24. Pijnenborg R, Vercruysse L, Hanssens M. The uterine spiral arteries in human pregnancy: Facts and controversies. Placenta 2006;27 939-958.
25. Rajagopalan S, Bryceson YT, Kuppusamy SP, Geraghty DE, van der Meer A, Joosten I, Long EO. Activation of NK cells by an endocytosed receptor for soluble HLA-G. PLoS Biol 2006;4:e9.
26. Raulet DH. Roles of the NKG2D immunoreceptor and its ligands. Nat Rev Immunol 2003;3:781-790.
27. Sargent IL, Borzychowski AM, Redman CW. NK cells and human pregnancy - an inflammatory view. Trends Immunol 2006;27:399-404.
28. Shibahara H, Suzuki T, Kikuchi K, Hirano Y, Suzuki M. Serum matrix metalloproteinase and tissue inhibitor of metalloproteinase concentrations in infertile women achieved pregnancy following IVF-ET. Am J Reprod Immunol 2005;54:186-192.
29. Smith S, Pfeifer SM, Collins JA. Diagnosis and management of female infertility. JAMA 2003;290:1767-1770.
30. Smyth MJ, Swann J, Cretney E, Zerafa N, Yokoyama WM, Hayakawa Y. NKG2D function protects the host from tumor initiation. J Exp Med 2005;202:583-588.
31. Sutherland CL, Chalupny NJ, Schooley K, VandenBos T, Kubin M, Cosman D. UL16-binding proteins, novel MHC class I-related proteins, bind to NKG2D and activate multiple signaling pathways in primary NK cells. J Immunol 2002;168:671-679.
32. Tabiasco J, Rabot M, Aguerre-Girr M, El Costa H, Berrebi A, Parant O, Laskarin G, Juretic K, Bensussan A, Rukavina Det al. Human decidual NK cells: Unique phenotype and functional properties - a review. Placenta 2006;27(Suppl. A):S34-S39.
33. Tong S, Marjono B, Brown DA, Mulvey S, Breit SN, Manuelpillai U, Wallace EM. Serum concentrations of macrophage inhibitory cytokine 1 (MIC 1) as a predictor of miscarriage. Lancet 2004;363:129-130.
34. Upshaw JL, Leibson PJ. NKG2D-mediated activation of cytotoxic lymphocytes: Unique signaling pathways and distinct functional outcomes. Semin Immunol 2006;18:167-175.
35. van der Meer A, Lukassen HG, van Cranenbroek B, Weiss EH, Braat DD, van Lierop MJ, Joosten I. Soluble HLA-G promotes Th1-type cytokine production by cytokine-activated uterine and peripheral natural killer cells. Mol Hum Reprod 2007;13:123-133.
36. Waldhauer I, Steinle A. Proteolytic release of soluble UL16-binding protein 2 from tumor cells. Cancer Res 2006;66:2520-2526.
37. Warner CM, Comiskey M, Clisham PR, Brenner CA. Soluble HLA-G (sHLA-G) a predictor of IVF outcome? J Assist Reprod Genet 2004; 21 315-316.
38. Wu JD, Higgins LM, Steinle A, Cosman D, Haugk K, Plymate SR. Prevalent expression of the immunostimulatory MHC class I cham-related molecule is counteracted by shedding in prostate cancer. J Clin Invest 2004; 114:560-568.